219 related articles for article (PubMed ID: 11743296)
21. Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies.
Boselli C; Govoni S; Condino AM; D'Agostino G
J Auton Pharmacol; 2001; 21(5-6):219-29. PubMed ID: 12123466
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
Mansfield KJ; Liu L; Moore KH; Vaux KJ; Millard RJ; Burcher E
BJU Int; 2007 Jun; 99(6):1433-8. PubMed ID: 17428242
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium.
Tyagi V; Philips BJ; Su R; Smaldone MC; Erickson VL; Chancellor MB; Yoshimura N; Tyagi P
J Urol; 2009 Apr; 181(4):1932-8. PubMed ID: 19237176
[TBL] [Abstract][Full Text] [Related]
24. Control of bladder function by peripheral nerves: avenues for novel drug targets.
Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
[TBL] [Abstract][Full Text] [Related]
25. Alteration in contractile responses in human detrusor smooth muscle from obstructed bladders with overactivity.
Kosan M; Tul M; Ozturk B; Hafez G; Inal G; Cetinkaya M
Urol Int; 2008; 80(2):193-200. PubMed ID: 18362492
[TBL] [Abstract][Full Text] [Related]
26. Possible role of bioactive peptides in the regulation of human detrusor smooth muscle - functional effects in vitro and immunohistochemical presence.
Uckert S; Stief CG; Lietz B; Burmester M; Jonas U; Machtens SA
World J Urol; 2002 Sep; 20(4):244-9. PubMed ID: 12215855
[TBL] [Abstract][Full Text] [Related]
27. The application of ultrastructural studies in the diagnosis of bladder dysfunction in a clinical setting.
Tse V; Wills E; Szonyi G; Khadra MH
J Urol; 2000 Feb; 163(2):535-9. PubMed ID: 10647673
[TBL] [Abstract][Full Text] [Related]
28. Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.
Roosen A; Apostolidis A; Elneil S; Khan S; Panicker J; Brandner S; Fowler CJ; Kessler TM
J Urol; 2009 Jul; 182(1):190-5. PubMed ID: 19450843
[TBL] [Abstract][Full Text] [Related]
29. Cholinergic and purinergic responses in isolated human detrusor in relation to age.
Wuest M; Morgenstern K; Graf EM; Braeter M; Hakenberg OW; Wirth MP; Ravens U
J Urol; 2005 Jun; 173(6):2182-9. PubMed ID: 15879884
[TBL] [Abstract][Full Text] [Related]
30. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis.
Birder LA; Ruan HZ; Chopra B; Xiang Z; Barrick S; Buffington CA; Roppolo JR; Ford AP; de Groat WC; Burnstock G
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1084-91. PubMed ID: 15251862
[TBL] [Abstract][Full Text] [Related]
31. Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle.
Fry CH; Bayliss M; Young JS; Hussain M
BJU Int; 2011 Jul; 108(2 Pt 2):E91-6. PubMed ID: 21070581
[TBL] [Abstract][Full Text] [Related]
32. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
[TBL] [Abstract][Full Text] [Related]
33. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor.
Tyagi S; Tyagi P; Van-le S; Yoshimura N; Chancellor MB; de Miguel F
J Urol; 2006 Oct; 176(4 Pt 1):1673-8. PubMed ID: 16952712
[TBL] [Abstract][Full Text] [Related]
34. Alterations in cholinergic and purinergic signaling in a model of the obstructed bladder.
Calvert RC; Thompson CS; Khan MA; Mikhailidis DP; Morgan RJ; Burnstock G
J Urol; 2001 Oct; 166(4):1530-3. PubMed ID: 11547126
[TBL] [Abstract][Full Text] [Related]
35. A putative alternatively spliced variant of the P2X(1) purinoreceptor in human bladder.
Hardy LA; Harvey IJ; Chambers P; Gillespie JI
Exp Physiol; 2000 Jul; 85(4):461-3. PubMed ID: 10918085
[TBL] [Abstract][Full Text] [Related]
36. The use of scopolamine in the treatment of detrusor instability.
Muskat Y; Bukovsky I; Schneider D; Langer R
J Urol; 1996 Dec; 156(6):1989-90. PubMed ID: 8911372
[TBL] [Abstract][Full Text] [Related]
37. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.
Choe JH; Choo MS; Lee KS
J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.
Semins MJ; Chancellor MB
Nat Clin Pract Urol; 2004 Dec; 1(2):78-84; quiz 109. PubMed ID: 16474519
[TBL] [Abstract][Full Text] [Related]
39. Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity.
Cucchi A; Quaglini S; Rovereto B
J Urol; 2007 Aug; 178(2):563-7; discussion 567. PubMed ID: 17570436
[TBL] [Abstract][Full Text] [Related]
40. A pilot study of Connexin 43 (Cx43) in human bladder tissue in patients with idiopathic detrusor overactivity.
Kuhn A; Stadlmayr W; Monga A; Cameron I; Anthony F
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):83-6. PubMed ID: 18687515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
